Loading clinical trials...
Loading clinical trials...
A Randomized, Open-Label, Multiple Dose, Two-Period Crossover Study Evaluating Maximum Use 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% in Men and Women with Primary Axillary Hyperhidrosis
Conditions
Interventions
WO3970
Qbrexza® (glycopyrronium) cloth, 2.4%, for topical use
Start Date
December 1, 2019
Primary Completion Date
October 1, 2020
Completion Date
October 1, 2020
Last Updated
December 24, 2024
NCT03658616
NCT03785587
NCT02286765
Lead Sponsor
Dr. August Wolff GmbH & Co. KG Arzneimittel
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions